Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-28

FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for torsemide submitted by Chartwell RX, LLC under ANDA 076894. The action approves changes to the torsemide product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Torsemide (torsemide)

Snippet

SUPPL AP for TORSEMIDE (TORSEMIDE)